Drugs / Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid
Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03017235 | Feb → Sep 2017 | — | Ferring Pharmaceuticals | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03017235 ↗ |
| Route | Oral | “Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution” NCT03017235 ↗ |